Chitosan-based wound dressing for diabetic foot ulcer treatment and burn wounds
Chitosan-based wound dressing that stimulates the closure, neovascularization and permanent regeneration of dermis in diabetic feet’s ulcers. It reduces the risk of amputation in patients.This innovation can also be used to prevent or treat wound and burn infections, not only due to its intrinsic antimicrobial properties, but also due to its ability to deliver extrinsic antimicrobial agents to wounds and burns. Additionally, it can be used as a slow-release drug-delivery vehicle for growth factors to stimulate and improve wound healing. This technology offers a complete regeneration of the ulcer using a single copy of the material without the need for invasive treatment, ensuring no backsliding in the development of ulcers. The purification process triggered by the chitosan and the ensuing chemical modifications in the membranes reduce possible allergic reactions and maximize the benefits, such as its antibacterial effects.